Vimarsana.com

Latest Breaking News On - Adial pharmaceuticals price performance - Page 1 : vimarsana.com

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Millennium-management
Adial-pharmaceuticals-price-performance
Nasdaq
Susquehanna-international-group
Virtu-financial
Adial-pharmaceuticals
Renaissance-technologies
Institutional-investors-weigh-in-on-adial-pharmaceuticals
Empirical-financial-services
News-ratings-for-adial-pharmaceuticals-daily
Adial-pharmaceuticals-inc

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Expected to Post FY2023 Earnings of ($5.46) Per Share

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Stock analysts at Brookline Capital Management decreased their FY2023 earnings per share (EPS) estimates for Adial Pharmaceuticals in a research note issued on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will earn ($5.46) per share for the year, down from […]

Adial-pharmaceuticals-inc
Nasdaq
Susquehanna-international-group
News-ratings-for-adial-pharmaceuticals-daily
Virtu-financial
Adial-pharmaceuticals
Adial-pharmaceuticals-price-performance
Empirical-financial-services
Millennium-management
Renaissance-technologies
Free-report

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Up 49.4% in September

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 50,800 shares, an increase of 49.4% from the September 15th total of 34,000 shares. Currently, 4.8% of the shares of the company are sold short. Based […]

Adial-pharmaceuticals-inc
News-ratings-for-adial-pharmaceuticals-daily
Adial-pharmaceuticals-price-performance
Renaissance-technologies
Millennium-management
Empirical-financial-services
Susquehanna-international-group
Nasdaq
Citadel-advisors
Institutional-investors-weigh-in-on-adial-pharmaceuticals
Adial-pharmaceuticals

Adial Pharmaceuticals, Inc. Expected to Post FY2023 Earnings of ($0.49) Per Share (NASDAQ:ADIL)

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research issued their FY2023 EPS estimates for Adial Pharmaceuticals in a report released on Monday, April 3rd. Litchfield Hills Research analyst T. O’neill anticipates that the company will earn ($0.49) per share for the year. The consensus estimate for Adial Pharmaceuticals’ […]

Bankolea-johnson
Adial-pharmaceuticals-price-performance
Renaissance-technologies
Empirical-financial-services
Millennium-management
Nasdaq
Citadel-advisors
Institutional-trading-of-adial-pharmaceuticals
Litchfield-hills-research
Adial-pharmaceuticals
News-ratings-for-adial-pharmaceuticals-daily

vimarsana © 2020. All Rights Reserved.